Listed by the USPTO as RADOSAVLJEVIC, ALEKSANDAR
Tech Center 1600 • Art Units: 1662
This examiner grants 81% of resolved cases
RADOSAVLJEVIC, ALEKSANDAR handles matters in Tech Center 1600 and Art Unit 1662. The record shows 125 resolved cases, an 80.8% allowance rate, and a median of 1043 days to allowance. Interviews have a 6.3% lift, indicating a positive but modest association with allowance outcomes.
The docket includes Inari Agriculture Technology Inc., Pioneer Hi-bred International Inc., and Syngenta AG. The listed firms are MCKEE, VOORHEES & SEASE, P.L.C., ARENTFOX SCHIFF LLP, and BANNER & WITCOFF, LTD. Practitioners handling agricultural technology matters can use the profile as a basis for combining conventional written prosecution with interviews where claim issues remain material.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18814176 | PLANT DERIVED INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE | Non-Final OA | PIONEER HI-BRED INTERNATIONAL, INC. |
| 19059554 | ENGINEERED PESTICIDAL PROTEINS AND METHODS OF CONTROLLING PLANT PESTS | Non-Final OA | Syngenta Crop Protection AG |
| 18007164 | GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI | Final Rejection | INARI AGRICULTURE TECHNOLOGY, INC. |
| 18007187 | GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING | Final Rejection | INARI AGRICULTURE TECHNOLOGY, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy80.8% of resolved applications examined by Aleksandar Radosavljevic were allowed (125 resolved cases), compared with 63.0% across Art Unit 1662 over the last five years.
This examiner's interview lift is +6.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Aleksandar Radosavljevic took 1,043 days on average from filing to allowance.
Aleksandar Radosavljevic examines applications in Art Unit 1662 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
